NTT DATA Named a Leader in IDC MarketScape for Life Science R&D Strategic Consulting Services

January 31, 2024

NTT DATA Group Corporation

TOKYO - January 31, 2024 - NTT DATA, a global digital business and IT services leader, today announced that it has been named a Leader in the IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services 2023 Vendor Assessment (doc # US49950023, December 2023). The report assesses 11 vendors' abilities to provide strategic services in areas such as process optimization, technology implementation, drug development, and digital health.

As life sciences companies adapt to changing post-pandemic conditions, they are seeking strategic guidance navigating ever-changing global scenarios, complying with rapidly evolving regulations, and adopting disruptive technologies such as generative AI. The IDC MarketScape named NTT DATA a Leader, saying its differentiators include its "domain expertise, digital transformation capabilities, intellectual property, and robust partner ecosystem, enabling it to drive innovation and digital transformation globally."

"Life sciences clients are looking for a partner that can accelerate their innovation agendas using technology and creativity during a time of rapid change," said Kaz Nishihata, Director and Senior Executive Vice President, NTT DATA Group Corporation. "We believe being recognized as a Leader in the prestigious IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services 2023 Vendor Assessment shows that NTT DATA has the expertise, experience, automation capabilities and track record of providing practical innovation to help them emerge as winners in the post-pandemic market."

The IDC MarketScape report states that life sciences clients should consider choosing NTT DATA "when seeking a digital and data transformation partner that develops innovative solutions for data integration and placement strategy, application rationalization and infrastructure optimization, and a company that can drive IT system blueprinting and M&A strategy."

NTT DATA has been serving the life sciences industry for more than 25 years and has over 90 clients in pharma, biotech, medical device, generics, and CRO. Key service areas include initiatives focused on manufacturing, supply chain, discovery preclinical, clinical development, sales and marketing, and patient management.

The IDC MarketScape report notes, "The top 5 areas in which NTT DATA supports its customers with its strategic consulting (SC) capabilities include the development of IT and application road maps, digital transformation, data analysis and insights, digital user experience, data privacy strategy, and infrastructure consulting."

According to the report, "NTT DATA helps clients drive workforce transformation and business resilience and build a data-driven enterprise through its modern workforce, connected infrastructure solutions, its Nucleus intelligent enterprise platform offering, and through "Launch by NTT DATA," where it partners with its clients to propel product strategy and development forward, enabling clients to scale digital experiences."

"At NTT DATA we're doubling down on investments in the life sciences space to help clients achieve their strategic goals," said Craig Hovda, President of the Healthcare and Life Sciences business, NTT DATA Services. "We've made key acquisitions that have strengthened our foundation, developed our service portfolio, and collaborated with partners to create AI accelerators for targeted life sciences use cases."

"In a world undergoing geopolitical disruption, the life sciences industry is leaning heavily on its SC partners to carve out its next-gen digital transformation strategy, architect roadmaps for the adoption of generative AI, provide strategic levers to design new-age business models and offer niche domain expertise. NTT DATA was recognized as a Leader in the IDC MarketScape for Strategic Consulting, with expertise in niche areas such as medical imaging, synthetic data generation, intelligent document processing, and clinical trial optimization, "said Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy and Technology, IDC.

For more information, please visit NTT DATA's Life Sciences page.